US 12421308
Anti-G-CSF antibodies and uses thereof
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 12421308 (Anti-G-CSF antibodies and uses thereof) held by ME Therapeutics Inc. expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ME Therapeutics Inc.
- Grant date
- Tue Sep 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K39/3955, A61P